Bioequivalence Study of Test and Reference Testosterone Topical Gel, 1.62% Metered Pump in Testosterone Deficient Adult Male Subjects Under Fasting Conditions

NCT02110368 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

32

Enrollment

INDUSTRY

Sponsor class

Conditions

Primary Hypogonadism
Hypogonadotropic Hypogonadism

Interventions

DRUG: Testosterone Topical Gel, 1.62% Metered Pump
DRUG: AndroGel (testosterone gel) 1.62% Metered-Dose Pump

Sponsor

Amneal Pharmaceuticals, LLC

Collaborators

[object Object]